OpenVSafe by OpenVAERS
Search V-safe

DQQ-27181-83133

1 vaccination 5 coded responses 12 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
12-15
ZIP prefix
038 / NH
Registered
2021-06-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-06-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-06-10
    Registered in v-safe
  3. 2021-06-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: Asthenia, Telemedicine, Vision blurred — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Systemic reaction (other): Blurred vision in right eye, weakness on left side of body (injection in left arm) · Healthcare visit (other): Telehealth Appointment to discuss vaccine effects including blurred vision in 2 days
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-06-10
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-06-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Joint pains
    Adult check-in
  6. 2021-06-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  7. 2021-06-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-06-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  9. 2021-06-14
  10. 2021-06-18
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-06-24
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-07-04
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  13. 2021-07-07
    Survey response — day 28, dose 1
    MedDRA: Injection site erythema, Injection site pruritus, Lethargy — Feeling: Fair
    Free text: Red itchy spot at site of injection, which had formerly healed - began/noticed today. Lethargy for past 2 weeks
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-07-16
    Survey response — day 35, dose 1
    MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fatigue
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  15. 2021-12-08
    Survey response — 6 months, dose 1
    MedDRA: Fatigue, Hypothyroidism, Infectious mononucleosis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Fatigue, hypothyroid, mononucleosis
    MedDRA releases: 2024-11 · check-in free text available
  16. 2021-12-08
    Report sent to call center — 6 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  17. 2021-12-09
  18. 2022-06-11
    Survey response — 12 months, dose 1
    MedDRA: Fatigue, Glucose tolerance impaired, Hormone level abnormal, Infectious mononucleosis, Office visit, Pernicious anaemia, Thyroid disorder — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Diagnosed with thyroid condition, mono (still experiencing extreme fatigue after 7+ months) Prediabetes, pernicious anemia, and disrupted hormones. · Healthcare visit (other): Office visit
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-06-11
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2022-06-13
  21. 2022-06-13
  22. 2022-06-13

Vaccinations

DoseDateManufacturerCo-administered
12021-06-09Pfizer-BioNTech

Call center

3 call center cases

3 unsuccessful

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 1

2021-06-10

Systemic reaction (other): Blurred vision in right eye, weakness on left side of body (injection in left arm)
Healthcare visit (other): Telehealth Appointment to discuss vaccine effects including blurred vision in 2 days

Release 9 — day 28, dose 1

2021-07-07

Symptoms: Red itchy spot at site of injection, which had formerly healed - began/noticed today. Lethargy for past 2 weeks

Release 9 — day 35, dose 1

2021-07-16

Symptoms: Fatigue

Release 10 — 6 months, dose 1

2021-12-08

Symptoms: Fatigue, hypothyroid, mononucleosis

Release 12 — 12 months, dose 1

2022-06-11

Symptoms: Diagnosed with thyroid condition, mono (still experiencing extreme fatigue after 7+ months) Prediabetes, pernicious anemia, and disrupted hormones.
Healthcare visit (other): Office visit

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOTelemedicine ✓ ✓ ✓
SDFatigue ✓ · ✓
SDGlucose tolerance impaired · · ✓
SDHormone level abnormal · · ✓
SDHypothyroidism · · ✓
SDInfectious mononucleosis · · ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDLethargy ✓ ✓ ✓
SDPernicious anaemia · · ✓
SDThyroid disorder · · ✓
SROAsthenia ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release